Zolmitriptan-d6 structure
|
Common Name | Zolmitriptan-d6 | ||
---|---|---|---|---|
CAS Number | 1217644-84-2 | Molecular Weight | 293.39 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C16H15D6N3O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Zolmitriptan-d6Zolmitriptan-d6 is deuterium labeled Zolmitriptan. Zolmitriptan (BW-311C90; 311C90) is a 5-HT1B/1D receptor partial agonist with Kis of 5.01 nM, 0.63 nM, and 63.09 nM for 5-HT1B, 5-HT1D, 5-HT1F receptor, respectively. Zolmitriptan can be used for the research of migraine[1][2]. |
Name | (5R)-5-[[3-[2-[bis(trideuteriomethyl)amino]ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one |
---|---|
Synonym | More Synonyms |
Description | Zolmitriptan-d6 is deuterium labeled Zolmitriptan. Zolmitriptan (BW-311C90; 311C90) is a 5-HT1B/1D receptor partial agonist with Kis of 5.01 nM, 0.63 nM, and 63.09 nM for 5-HT1B, 5-HT1D, 5-HT1F receptor, respectively. Zolmitriptan can be used for the research of migraine[1][2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C16H15D6N3O2 |
---|---|
Molecular Weight | 293.39 |
Exact Mass | 293.20100 |
PSA | 60.85000 |
LogP | 1.56290 |
[2H6]-Zolmitriptan |